124 related articles for article (PubMed ID: 32757512)
1. [Preventing TB among immigrants; aiming for an integrated approach to infectious diseases].
Erkens C; Spruijt I; van den Hof S
Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32757512
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
3. Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.
Spruijt I; Erkens C; Suurmond J; Huisman E; Koenders M; Kouw P; Toumanian S; Cobelens F; van den Hof S
PLoS One; 2019; 14(7):e0219252. PubMed ID: 31260502
[TBL] [Abstract][Full Text] [Related]
4. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost effectiveness of screening immigrants schemes for tuberculosis (TB) on arrival from high TB endemic countries to low TB prevalent countries.
Sanneh AF; Al-Shareef AM
Afr Health Sci; 2014 Sep; 14(3):663-71. PubMed ID: 25352886
[TBL] [Abstract][Full Text] [Related]
6. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
Wilson FA; Miller TL; Stimpson JP
Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
[TBL] [Abstract][Full Text] [Related]
8. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study.
Winje BA; Grøneng GM; White RA; Akre P; Aavitsland P; Heldal E
BMJ Open; 2019 Jan; 9(1):e023412. PubMed ID: 30782706
[TBL] [Abstract][Full Text] [Related]
9. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
10. Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong.
Wong NS; Chan KCW; Wong BCK; Leung CC; Chan WK; Lin AWC; Lui GCY; Mitchell KM; Lee SS
JAMA Netw Open; 2019 Sep; 2(9):e1910960. PubMed ID: 31490541
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of primary care based risk stratification for targeted latent tuberculosis infection screening in recent immigrants to the UK: a retrospective cohort study.
Panchal RK; Browne I; Monk P; Woltmann G; Haldar P
Thorax; 2014 Apr; 69(4):354-62. PubMed ID: 24253833
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.
Campbell JR; Sasitharan T; Marra F
Appl Health Econ Health Policy; 2015 Aug; 13(4):325-40. PubMed ID: 26129810
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
Diel R; Lampenius N; Nienhaus A
Pharmacoeconomics; 2015 Aug; 33(8):783-809. PubMed ID: 25774015
[TBL] [Abstract][Full Text] [Related]
15. Can Australia eliminate TB? Modelling immigration strategies for reaching MDG targets in a low-transmission setting.
Denholm JT; McBryde ES
Aust N Z J Public Health; 2014 Feb; 38(1):78-82. PubMed ID: 24494951
[TBL] [Abstract][Full Text] [Related]
16. Preventing tuberculosis in the foreign-born population of Canada: a mathematical modelling study.
Varughese MB; Langlois-Klassen D; Long R; Li M
Int J Tuberc Lung Dis; 2014 Apr; 18(4):405-12. PubMed ID: 24670694
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
Loureiro RB; Maciel ELN; Caetano R; Peres RL; Fregona G; Golub JE; Braga JU
PLoS One; 2019; 14(11):e0225197. PubMed ID: 31725786
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
Usemann J; Ledergerber M; Fink G; Ritz N
Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
[TBL] [Abstract][Full Text] [Related]
19. A screening strategy for latent tuberculosis in healthcare workers: Cost-effectiveness and budget impact of universal versus targeted screening.
Png ME; Yoong J; Ong CWM; Fisher D; Bagdasarian N
Infect Control Hosp Epidemiol; 2019 Mar; 40(3):341-349. PubMed ID: 30786941
[TBL] [Abstract][Full Text] [Related]
20. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
